Market Overview

RBC Capital Maintains Outperform on Aerie Pharmaceuticals, Lowers PT to $27.00

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for AERI

DateFirmActionFromTo
Mar 2017Raymond JamesDowngradesStrong BuyMarket Perform
Feb 2017Cowen & Co.Initiates Coverage OnOutperform
Feb 2017Roth CapitalInitiates Coverage OnBuy

View More Analyst Ratings for AERI
View the Latest Analyst Ratings

Posted-In: News Price Target Analyst Ratings

 

Related Articles (AERI)